Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15

Author： Ishiguro Megumi   Iida Satoru   Uetake Hiroyuki   Morita Shinji   Makino Hiroshi   Kato Keiji   Takagi Yoko   Enomoto Masayuki   Sugihara Kenichi  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.14, Iss.5, 2007-05, pp. : 1752-1762

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of combined 5-aza-2'deoxycytidine and cisplatin treatment on the P15 lung adenocarcinoma cell line

By        

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2007-2012

Spandidos Publications

Access to resources Recommend Favorite

Rapamycin synergizes with low dose oxaliplatin in the HCT116 colon cancer cell line by inducing enhanced apoptosis

By            

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 643-647

Spandidos Publications

Access to resources Recommend Favorite

Effects of 5Aza2'deoxycytidine on the methylation state and function of the WWOX gene in the HO8910 ovarian cancer cell line

By      

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 845-849

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer

By Chu B.   Karpenko M.   Liu Z.   Aimiuwu J.   Villalona-Calero M.   Chan K.   Grever M.   Otterson G.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 115-121

Springer Publishing Company

Access to resources Recommend Favorite

Continuous Low-Dose Combined Hormone Replacement Therapy and the Risk of Endometrial Cancer

By Comerci J.T.   Fields A.L.   Runowicz C.D.   Goldberg G.L.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 425-430

Elsevier

Access to resources Recommend Favorite